Preferred Label : Lymphoproliferative syndrome 2;
Symbol : LPFS2;
CISMeF acronym : LPFS2;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Cd27 deficiency;
Description : Lymphoproliferative syndrome-2, also known as CD27 deficiency, is an autosomal recessive
immunodeficiency disorder associated with persistent symptomatic EBV viremia, hypogammaglobulinemia,
and impairment in specific antibody function resulting from impaired T cell-dependent
B-cell responses and T-cell dysfunction (summary by van Montfrans et al., 2012). The
phenotype can vary significantly, from asymptomatic borderline-low hypogammaglobulinemia,
to a full-blown symptomatic systemic inflammatory response with life-threatening EBV-related
complications, including hemophagocytic lymphohistiocytosis, a lymphoproliferative
disorder, and malignant lymphoma requiring stem cell transplantation (summary by Salzer
et al., 2013). For a discussion of genetic heterogeneity of lymphoproliferative syndrome,
see XLP1 (308240).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the tumor necrosis factor receptor superfamily, member 7 gene
(TNFRSF7, 186711.0001);
Neoplasia : Lymphoproliferative disorder (in some patients); Hemophagocytic lymphohistiocytosis (in some patients); Lymphoma (in some patients);
Laboratory abnormalities : Increased susceptibility to EBV infection; Persistent EBV viremia; Decreased fibrinogen (in some patients);
Prefixed ID : #615122;
Origin ID : 615122;
UMLS CUI : C3554540;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)